Former Geisinger head to run CMS Innovation Center

NewsGuard 100/100 Score

CQ HealthBeat reports that Richard Gilfillan, a former head of the Geisinger Health Plan in Pennsylvania, will run the Center for Medicare and Medicaid Services Innovation Center that was created by the health law. Gilfillan was chosen Monday. At Geisinger, Gilfillan ran a plan that "many health policy analysts see as a national model for delivering quality, affordable care" (Reichard, 9/27).

The Hill : "Gilfillan, a family physician by training, currently heads performance-based policy at CMS" (Pecquet, 9/28).

Health Affairs Blog: "The Affordable Care Act gives the Innovation Center the crucial mission of testing "innovative payment and service delivery models to reduce program expenditures…while preserving or enhancing quality of care." A CMS spokesperson said that Gilfillan was named in an acting capacity to quickly fill a role vital to the implementation of health reform; the spokesperson said he could not at this point provide a timetable for filling the position on a permanent basis" (Fleming, 9/27).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Increased drug coverage restrictions in Medicare Part D raises concerns